<bill session="117" type="h" number="9127" updated="2023-02-17T17:30:25Z">
  <state datetime="2022-10-04">REFERRED</state>
  <status>
    <introduced datetime="2022-10-04"/>
  </status>
  <introduced datetime="2022-10-04"/>
  <titles>
    <title type="display">Mandating Exclusive Review of Individual Treatments (MERIT) Act</title>
    <title type="short" as="introduced">Mandating Exclusive Review of Individual Treatments (MERIT) Act</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to clarify the use of the national coverage determination process under the Medicare program.</title>
  </titles>
  <sponsor bioguide_id="B001260"/>
  <cosponsors>
    <cosponsor bioguide_id="B001300" joined="2022-10-04"/>
    <cosponsor bioguide_id="D000628" joined="2022-10-18"/>
    <cosponsor bioguide_id="F000465" joined="2022-10-14"/>
    <cosponsor bioguide_id="F000466" joined="2022-10-14"/>
    <cosponsor bioguide_id="M001215" joined="2022-10-25"/>
    <cosponsor bioguide_id="R000609" joined="2022-12-13"/>
    <cosponsor bioguide_id="S000168" joined="2022-10-21"/>
    <cosponsor bioguide_id="S001172" joined="2022-10-25"/>
  </cosponsors>
  <actions>
    <action datetime="2022-10-04">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-10-04" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2022-10-04">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2022-10-05">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Medical research"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2023-02-14T21:15:29Z" status="Introduced in House">Mandating Exclusive Review of Individual Treatments (MERIT) Act

This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.</summary>
</bill>
